Helen L. Parker

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances

Published: December 09, 2025

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances

Published: December 09, 2025

Exploring the synergy between telomere length and genomic complexity in CLL.

Exploring the synergy between telomere length and genomic complexity in CLL.

Journal: British journal of haematology

Published: August 20, 2025

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Journal: Leukemia

Published: December 20, 2024

Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.

Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.

Journal: British journal of haematology

Published: June 11, 2024

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Journal: Blood advances

Published: April 03, 2024

Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies.

Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies.

Journal: Molecular genetics and metabolism

Published: March 12, 2024

The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.

The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.

Journal: Exploration of targeted anti-tumor therapy

Published: February 27, 2024

Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy.

Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy.

Journal: Molecular therapy. Methods & clinical development

Published: July 18, 2023

Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease.

Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease.

Journal: EMBO molecular medicine

Published: July 07, 2023

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Journal: Leukemia

Published: January 12, 2023

Graphene oxide modulates dendritic cell ability to promote T cell activation and cytokine production.

Graphene oxide modulates dendritic cell ability to promote T cell activation and cytokine production.

Journal: Nanoscale

Published: November 14, 2022

Showing 1-12 of 68

Last Updated: 09/26/2026